首页> 美国卫生研究院文献>Neuroscience Bulletin >A review on research progress of transketolase
【2h】

A review on research progress of transketolase

机译:转酮醇酶的研究进展综述

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Transketolase (TK), a thiamine diphosphate (ThDP)-dependent enzyme, catalyzes several key reactions of nonoxidative branch of pentose phosphate pathway. TK is a homodimer with two active sites that locate at the interface between the contacting monomers. Both ThDP and bivalent cations are strictly needed for TK activation, just like that for all ThDP-dependent enzymes. TK exists in all organisms that have been investigated. Up to now, one TK gene (TKT) and two transketolase-like genes (TKTL1 and TKTL2) have been identified in human genome. TKTL1 is reported to play a pivotal role in carcinogenesis and may have important implications in the nutrition and future treatment of patients with cancer. Researchers have found TK variants and reduced activities of TK enzyme in patients with neurodegenerative diseases, diabetes, and cancer. Recent studies indicated TK as a novel role in the prevention and therapy of these diseases.
机译:转酮醇酶(TK),一种硫胺素二磷酸(ThDP)依赖性酶,催化戊糖磷酸途径非氧化分支的几个关键反应。 TK是具有两个活性位点的同型二聚体,其位于接触单体之间的界面上。 TK激活完全需要ThDP和二价阳离子,就像所有依赖ThDP的酶一样。传统知识存在于所有已调查的生物中。到目前为止,在人类基因组中已经鉴定出一个TK基因(TKT)和两个转酮醇酶样基因(TKTL1和TKTL2)。据报道,TKTL1在致癌作用中起着关键作用,并且可能对癌症患者的营养和未来治疗产生重要影响。研究人员发现患有神经退行性疾病,糖尿病和癌症的患者的TK变异和TK酶活性降低。最近的研究表明,传统知识在这些疾病的预防和治疗中具有新的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号